# Effect and Safety of Propofol Fumarate for Mother-to-child Blocking of Hepatitis B

> **NCT04135235** · — · UNKNOWN · sponsor: **Beijing Ditan Hospital** · enrollment: 440 (estimated)

## Conditions studied

- Chronic Hepatitis B Infection
- High Viral Load

## Interventions

- **DRUG:** TAF
- **DRUG:** TDF

## Key facts

- **NCT ID:** NCT04135235
- **Lead sponsor:** Beijing Ditan Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-08-01
- **Primary completion:** 2021-08-01
- **Final completion:** 2021-08-01
- **Target enrollment:** 440 (ESTIMATED)
- **Last updated:** 2019-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04135235

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04135235, "Effect and Safety of Propofol Fumarate for Mother-to-child Blocking of Hepatitis B". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04135235. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*